Antibiotic resistance: Why common infections are getting harder to treat

Antibiotics once turned deadly infections into curable ones. That trust is now cracking. Across hospitals and homes, germs are learning how to survive these medicines. This change is called antibiotic resistance. A simple UTI, a case of pneumonia, or a post-surgery infection can suddenly refuse to respond to treatment. Recent ICMR report shows this is no longer a future risk. It is already happening.

Antibiotic resistance happens when bacteria change and stop responding to antibiotics. The medicine does not weaken. The bacteria grow smarter. They learn how to block the drug, push it out, or survive despite it. These resistant bacteria then multiply and spread. Over time, the same antibiotic that once worked well becomes almost useless.

This is not the body becoming resistant. It is the bacteria adapting faster than new medicines are made.

When antibiotics fail, infections last longer and grow more severe. Patients may need stronger drugs, longer hospital stays, or ICU care. In some cases, treatment options run out completely. This raises the risk of complications and death, especially for newborns, older adults, and critically ill patients.

Resistance also affects routine care. Surgeries, cancer treatment, dialysis, and organ transplants all rely on effective antibiotics to prevent infections. When these drugs fail, even planned medical procedures become risky.

The ICMR Antimicrobial Resistance Research & Surveillance Network report for 2024 studied nearly one lakh hospital infection samples. The findings are alarming.

Gram-negative bacteria caused about 72 percent of bloodstream infections. E. coli, a common cause of UTIs and abdominal infections, showed falling response to many first-line antibiotics. Klebsiella pneumoniae remained resistant to piperacillin-tazobactam in most cases and showed high resistance to carbapenems, often considered last-resort drugs.

In ICUs, the situation is even worse. Acinetobacter baumannii showed 91 percent resistance to meropenem. Doctors are often forced to use toxic or complex drug combinations. Diarrhoeal infections showed high resistance to common drugs, and over 95 percent of Salmonella typhi samples resisted fluoroquinolones. Fungal threats are rising too, with Candida auris showing resistance in nearly one-tenth of samples.

These numbers point to a system under strain, not isolated failures.

Antibiotics are often taken without testing, without prescriptions, or stopped midway. Each misuse gives bacteria a training session. They learn how to survive the next attack. Over time, this habit weakens entire drug classes.
Cold, flu, and viral fevers do not need antibiotics, yet these medicines are still used casually. This false sense of quick relief has come at a heavy cost. The more antibiotics are used blindly, the faster resistance spreads.

Prime Minister Narendra Modi recently shared concerns from the ICMR report on social media. He warned that antibiotics are becoming weaker against diseases like pneumonia and UTIs. He clearly pointed to careless use as a major cause. His message was simple and firm. Antibiotics are not everyday pills. They must be taken only on a doctor’s advice.

He also highlighted a growing mindset where one pill is expected to fix every problem. That belief, he said, is allowing infections to overpower medicines. His call was not about fear. It was about responsibility and discipline in medicine use.

Experts stress the need for antibiotic stewardship. This means using the right drug, at the right dose, for the right duration. Hospitals must strengthen infection control. Doctors need better diagnostic support. Pharmacies must discourage over-the-counter antibiotic sales.
At a personal level, small choices matter. Completing prescribed courses, avoiding self-medication, and trusting medical guidance can slow resistance. The goal is not to avoid antibiotics, but to protect them so they still work when truly needed.